Clinical Trials
2 trialsNCT05394233 2022-05-27
Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT03127319 2018-01-17
A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases
Affiliated Hospital of Hebei University
Phase 2 Unknown